Revenue ($USD) : $1,376,096,000
R&D spend : $60,918,000.00
Employees : 10,000
Fiscal year end : 12/31/22
CEO : Joseph Dziedzic, president and CEO

Integer's sales rose nearly 18% year-over-year to nearly $779 million during the first half of 2023. The medtech contract manufacturing giant’s strong results caused Integer to boost its full-year sales outlook to 1 2% growth at the midpoint.

In Integer’s Q2 earnings news release, CEO Joseph Dziedzic said: “Integer delivered another strong quarter of sales and profit growth supported by an improving supply chain and labor environment.” –CN